Log in to save to my catalogue

1472 Targeting PDGFRb for superior bladder cancer treatment

1472 Targeting PDGFRb for superior bladder cancer treatment

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1e3a037cbc58467b9c0585acd3b5f0e8

1472 Targeting PDGFRb for superior bladder cancer treatment

About this item

Full title

1472 Targeting PDGFRb for superior bladder cancer treatment

Publisher

London: BMJ Publishing Group Ltd

Journal title

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A1636-A1636

Language

English

Formats

Publication information

Publisher

London: BMJ Publishing Group Ltd

More information

Scope and Contents

Contents

BackgroundBladder cancer (BC) is a very significant world public health problem. The high rate of recurrence of non-muscle invasive BC and the low patient survival rates of advanced BC emphasize the need to better stratify patients and to improve the outcome of current immunotherapies. Here we aim at identifying new players driving BC recurrence an...

Alternative Titles

Full title

1472 Targeting PDGFRb for superior bladder cancer treatment

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_1e3a037cbc58467b9c0585acd3b5f0e8

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1e3a037cbc58467b9c0585acd3b5f0e8

Other Identifiers

E-ISSN

2051-1426

DOI

10.1136/jitc-2023-SITC2023.1472

How to access this item